bpc-157 clinical trial humans randomized Discover BPC-157: its first randomized, placebo-controlled human is now recruiting. Thirty years of preclinical data and exactly one prior human study defined the evidence base until now. A 2025 systematic review Overall, 14 of 16 patients

BPC 157 was given per-orally in drinking water (10 g/kg, 12 ml/rat/day) until sacrifice, or 10 g/kg or 10 ng/kg was given intraperitoneally once daily, with the first application at 30 min after surgery and the last application at 24 h before sacrifice

Swab the stopper before the reconstitution syringe enters it, and again before each weekly dose draw

Butyrate appears also involved in reducing the immune response to LPS, helping T-cell differentiations, and decrease IL-6 and IL-12 secretion

The uneducated clinicians will say, you dont have Intrinsic factor antibodies (IFA) so you dont have pernicious anaemia (PA) and so you will stay on tablets because we decided you can now miraculously absorb B12 from food! This ludicrous concept crops up frequently (I have blogged about it before here.) It needs repeating so often PA is just one of many causes and they are all serious and need correct treatment

Multiple animal studies demonstrate significantly accelerated healing of Achilles tendon, rotator cuff, and medial collateral ligament injuries